Bright Minds Biosciences (DRUG) Operating Income (2023 - 2024)
Bright Minds Biosciences' (DRUG) quarterly Operating Income came in at $32422.2 in Q4 2024, up 102.62% YoY from $16001.4 in Q1 2024, and down 79.37% on a QoQ basis from $157133.8 in Q2 2024.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Operating Income (2023 - 2024) Analysis & Trends
Bright Minds Biosciences (DRUG) has 2 years of Operating Income data on file, last reported at $32422.2 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | -815.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -505.13 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 325.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Bright Minds Biosciences | 455.12 Mn | 232.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 32,422.24 |
| Jun 30, 2024 | 157,133.80 |
| Dec 31, 2023 | -1.24 Mn |
| Jun 30, 2023 | -1.09 Mn |